DEFINITIVE PROXY STATEMENT

Company

Vistagen Therapeutics, Inc.

Filed

July 29, 2021

Period of Report

September 17, 2021

Accession Number

0001654954-21-008334

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →